204 related articles for article (PubMed ID: 31197859)
1. Exploring the systematic effect of N-substituted PxxP motifs on peptoid affinity to ARHGEF5/TIM SH3 domain and its relationship with ARHGEF5/TIM activation.
Fu Y; He P; Zhou Y; Huang S; Liang L; Liu S
Proteins; 2019 Nov; 87(11):979-991. PubMed ID: 31197859
[TBL] [Abstract][Full Text] [Related]
2. The auto-inhibitory state of Rho guanine nucleotide exchange factor ARHGEF5/TIM can be relieved by targeting its SH3 domain with rationally designed peptide aptamers.
He P; Tan DL; Liu HX; Lv FL; Wu W
Biochimie; 2015 Apr; 111():10-8. PubMed ID: 25645980
[TBL] [Abstract][Full Text] [Related]
3. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
Han S; Liu Q; Wang F; Yuan Z
J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
[TBL] [Abstract][Full Text] [Related]
4. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
[TBL] [Abstract][Full Text] [Related]
5. Molecular design and optimization of hepatic cancer SLP76-derived PLCγ1 SH3-binding peptide with the systematic N-substitution of peptide PXXP motif.
Tang W; Zhao Z; Wang C; Ye T; Yang B
J Mol Recognit; 2019 Dec; 32(12):e2806. PubMed ID: 31397025
[TBL] [Abstract][Full Text] [Related]
6. N-substituting perturbation on the interaction affinity and recognition specificity between rheumatic immune-related Abl SH3 domain and its peptoid ligands.
Tang X; Chen J; Cai J; Wang Q
J Mol Graph Model; 2023 Dec; 125():108601. PubMed ID: 37607432
[TBL] [Abstract][Full Text] [Related]
7. Targeting rho guanine nucleotide exchange factor ARHGEF5/TIM with auto-inhibitory peptides in human breast cancer.
Huang O; Wu D; Xie F; Lin L; Wang X; Jiang M; Li Y; Chen W; Shen K; Hu X
Amino Acids; 2015 Jun; 47(6):1239-46. PubMed ID: 25743165
[TBL] [Abstract][Full Text] [Related]
8. Dynamics simulation, energetics calculation and experimental analysis of the intermolecular interaction between human neonatal ABL SH3 domain and its
Zhao S; Shen L; Wang Q; Lu W
J Biomol Struct Dyn; 2023 Nov; ():1-8. PubMed ID: 37909467
[TBL] [Abstract][Full Text] [Related]
9. Improving SH3 domain ligand selectivity using a non-natural scaffold.
Nguyen JT; Porter M; Amoui M; Miller WT; Zuckermann RN; Lim WA
Chem Biol; 2000 Jul; 7(7):463-73. PubMed ID: 10903934
[TBL] [Abstract][Full Text] [Related]
10. Why the first self-binding peptide of human
Zhou P; Yan F; Miao Q; Chen Z; Wang H
J Biomol Struct Dyn; 2021 Jan; 39(1):310-318. PubMed ID: 31872783
[TBL] [Abstract][Full Text] [Related]
11. The Binding of Syndapin SH3 Domain to Dynamin Proline-rich Domain Involves Short and Long Distance Elements.
Luo L; Xue J; Kwan A; Gamsjaeger R; Wielens J; von Kleist L; Cubeddu L; Guo Z; Stow JL; Parker MW; Mackay JP; Robinson PJ
J Biol Chem; 2016 Apr; 291(18):9411-24. PubMed ID: 26893375
[TBL] [Abstract][Full Text] [Related]
12. The SH3 domain of a M7 interacts with its C-terminal proline-rich region.
Wang Q; Deloia MA; Kang Y; Litchke C; Zhang N; Titus MA; Walters KJ
Protein Sci; 2007 Feb; 16(2):189-96. PubMed ID: 17189480
[TBL] [Abstract][Full Text] [Related]
13. Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.
Kami K; Takeya R; Sumimoto H; Kohda D
EMBO J; 2002 Aug; 21(16):4268-76. PubMed ID: 12169629
[TBL] [Abstract][Full Text] [Related]
14. Identification of polyproline II regions derived from the proline-rich nuclear receptor coactivators PNRC and PNRC2: new insights for ERα coactivator interactions.
Byrne C; Miclet E; Broutin I; Gallo D; Pelekanou V; Kampa M; Castanas E; Leclercq G; Jacquot Y
Chirality; 2013 Oct; 25(10):628-42. PubMed ID: 23925889
[TBL] [Abstract][Full Text] [Related]
15. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
16. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
Cobos ES; Pisabarro MT; Vega MC; Lacroix E; Serrano L; Ruiz-Sanz J; Martinez JC
J Mol Biol; 2004 Sep; 342(1):355-65. PubMed ID: 15313630
[TBL] [Abstract][Full Text] [Related]
17. Role of the C-terminal SH3 domain and N-terminal tyrosine phosphorylation in regulation of Tim and related Dbl-family proteins.
Yohe ME; Rossman K; Sondek J
Biochemistry; 2008 Jul; 47(26):6827-39. PubMed ID: 18537266
[TBL] [Abstract][Full Text] [Related]
18. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the thermodynamics of binding of an SH3 domain to proline-rich peptides using a chimeric fusion protein.
Candel AM; van Nuland NA; Martin-Sierra FM; Martinez JC; Conejero-Lara F
J Mol Biol; 2008 Mar; 377(1):117-35. PubMed ID: 18234212
[TBL] [Abstract][Full Text] [Related]
20. Structural basis of PxxDY motif recognition in SH3 binding.
Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
